|Myocardial tissue Doppler echocardiography and N-terminal B-type natriuretic peptide (NT-proBNP) in diastolic and systolic heart failure.|
|Jump to Full Text|
|PMID: 18778476 Owner: NLM Status: MEDLINE|
|BACKGROUND: The aim of this prospective study was to assess the diagnostic value of NT-proBNP and the concordance with Tissue Doppler Echocardiography (including strain and longitudinal displacement) in diastolic and systolic heart failure.
METHODS AND RESULTS: 137 consecutive clinically stable patients were included (42 healthy controls, 43 with diastolic heart failure, 52 with systolic heart failure). In diastolic heart failure, basal septal strain was reduced (-24.8 +/- 8.1% vs. controls. -18.5 +/- 5.3%, p < 0.0001). In all patients with preserved systolic function, septal basal longitudinal displacement was impaired in patients with increased left-ventricular filling pressures (E/E' < 8: 13.5 mm +/- 3.3 mm vs. E/E' > 15: 8.5 mm +/- 2.3 mm, p = 0.001) parallel to NT-proBNP elevation (E/E' < 8: 45.8 pg/ml, IQR: 172.5 pg/ml vs. E/E' > 15: 402.0 pg/ml, IQR: 1337.2 pg/ml; p = 0.0007). In ROC analysis, NT-proBNP could detect patients with reduced left ventricular systolic function (LVEF >or= 55%) with a good diagnostic accuracy. However, the diagnostic accuracy of NT-proBNP to detect diastolic dysfunction was lower.
CONCLUSION: Subtle changes of longitudinal myocardial function begin in diastolic heart failure and are further increased in systolic heart failure. In patients with preserved LV function, a complex approach with the integration of multiple parameters including Tissue Doppler echocardiography and NT-proBNP is necessary to classify patients.
|Fabian Knebel; Stephan Eddicks; Ingolf Schimke; Michael Bierbaum; Sebastian Schattke; Mark Beling; Vanessa Raab; Gert Baumann; Adrian C Borges|
Related Documents :
|15184726 - Effect of bisoprolol on right ventricular function and brain natriuretic peptide in pat...
14574056 - The role of brain natriuretic peptide in population screening.
10573286 - Regulating the activity of a cardioacceleratory peptide.
20812386 - N-terminal fragment of pro-brain natriuretic peptide (nt-probnp) for predicting silent ...
11432476 - The role of endothelin-b receptors in myocardial and endothelial reperfusion injury aft...
20676586 - Evaluation of the metabolism of high energy phosphates in patients with chagas' disease.
|Type: Journal Article Date: 2008-09-08|
|Title: Cardiovascular ultrasound Volume: 6 ISSN: 1476-7120 ISO Abbreviation: Cardiovasc Ultrasound Publication Date: 2008|
|Created Date: 2008-09-19 Completed Date: 2008-12-10 Revised Date: 2013-06-05|
Medline Journal Info:
|Nlm Unique ID: 101159952 Medline TA: Cardiovasc Ultrasound Country: England|
|Languages: eng Pagination: 45 Citation Subset: IM|
|Universitätsmedizin Berlin, Medical Clinic for Cardiology and Angiology, Charité Campus Mitte, Charitéplatz 1, Berlin, Germany. email@example.com|
|APA/MLA Format Download EndNote Download BibTex|
Heart / physiopathology
Heart Failure, Diastolic / blood*, physiopathology, ultrasonography*
Heart Failure, Systolic / blood*, physiopathology, ultrasonography*
Natriuretic Peptide, Brain / blood*
Peptide Fragments / blood*
Severity of Illness Index
|0/Peptide Fragments; 0/pro-brain natriuretic peptide (1-76); 114471-18-0/Natriuretic Peptide, Brain|
Journal ID (nlm-ta): Cardiovasc Ultrasound
Publisher: BioMed Central
Copyright ? 2008 Knebel et al; licensee BioMed Central Ltd.
open-access: This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received Day: 2 Month: 8 Year: 2008
Accepted Day: 8 Month: 9 Year: 2008
collection publication date: Year: 2008
Electronic publication date: Day: 8 Month: 9 Year: 2008
Volume: 6First Page: 45 Last Page: 45
Publisher Id: 1476-7120-6-45
PubMed Id: 18778476
|Myocardial tissue Doppler echocardiography and N-terminal B-type natriuretic peptide (NT-proBNP) in diastolic and systolic heart failure|
|Fabian Knebel1||Email: firstname.lastname@example.org|
|Stephan Eddicks1||Email: email@example.com|
|Ingolf Schimke1||Email: firstname.lastname@example.org|
|Michael Bierbaum2||Email: email@example.com|
|Sebastian Schattke1||Email: firstname.lastname@example.org|
|Mark Beling1||Email: email@example.com|
|Vanessa Raab3||Email: firstname.lastname@example.org|
|Gert Baumann1||Email: email@example.com|
|Adrian C Borges1||Email: firstname.lastname@example.org|
1Universit?tsmedizin Berlin, Medical Clinic for Cardiology and Angiology, Charit? Campus Mitte, Charit?platz 1, 10098 Berlin, Germany
2Parit?tisches Krankenhaus Lichtenberg, Fanningerstra? 32, 10365 Berlin, Germany
3St?dtisches Klinikum M?nchen Schwabing, K?lner Platz 1, 80804 Munich, Germany
The prevalence of both systolic and diastolic heart failure is high and the prognosis is comparably poor. The prevalence of diastolic heart failure is increasing and the survival rates remain low, whereas the survival rates of systolic heart failure have improved in recent years. Diastolic heart failure is characterized by abnormal myocardial relaxation and increased passive stiffness and is hard to distinguish from systolic heart failure by clinical examination alone [1-8].
It was suggested that there is no isolated diastolic dysfunction, but that there is a continuum from normal to impaired diastolic and then systolic dysfunction (concept of "single syndrome"). The impairment of the longitudinal systolic function measured by Tissue Doppler Imaging (TDI) in patients with diastolic dysfunction supports this concept [9-11]. In contrast, the "two syndromes" concept claims two different pathological entities in systolic and diastolic heart failure. However, there is no final consensus on the taxonomy and the optimal diagnostic algorithm for the detection of diastolic dysfunction. Symptoms of heart failure, biomarkers, stress tests, and echocardiography are important elements in the diagnostic work up .
The non-invasive methods to diagnose heart failure include echocardiography and cardiac biomakers. Increased left-ventricular filling pressure is believed to induce myocardial wall-stress, the release of natriuretic peptides and increased E/E'-ratio. Diastolic heart failure is unlikely if E/E' is < 8, an E/E' 8?15 is suggestive of but not diagnostic of diastolic heart failure [13,14].
In addition to myocardial velocity measurements, new sensitive TDI-derived measurements of systolic function were introduced recently: Strain and longitudinal displacement . Strain measures compression and distension of myocardial segments ("deformation imaging") and is reduced in systolic dysfunction [16,17]. Longitudinal displacement measures myocardial motion amplitudes in systole and visualizes the segmental velocity-time integrals. It correlates with longitudinal systolic function  but has not yet been examined in isolated diastolic dysfunction.
Natriuretic peptides (BNP and the hormonally inactive NT-proBNP) are significantly elevated in systolic and in less so in diastolic heart failure [19-22]. NT-proBNP correlates to prognosis in systolic heart failure [23,24], but its diagnostic value in stable asymptomatic patients with diastolic heart failure is still controversial.
The aim of this study was to assess the diagnostic value of NT-proBNP and the concordance with Tissue Doppler Echocardiography (Strain imaging, longitudinal displacement, E/E') in diastolic and systolic heart failure. We postulate that the integration of these parameters improves the severity estimation of systolic and diastolic heart failure.
In this prospective monocentric study (enrolment 2004?2005), 137 consecutive clinically stable out- and in-patients with a clinical indication for echocardiography from medical and surgical departments were included. Exclusion criteria: atrial fibrillation, relevant valvular heart disease exceeding mild mitral or aortic valve disease, prosthetic heart valves, pulmonary hypertension, myocardial infarction < 3 months prior to study inclusion, terminal renal failure, creatinine > 2.5 mg/dl, pregnancy, age < 18 years. The blood for NT-proBNP measurements (Elecsys proBNP, Roche Diagnostics, Germany  was drawn after echocardiography, centrifuged and frozen at -80?C immediately. The echocardiography examiners were blinded to the NT-proBNP values. The creatinine clearance was calculated as previously described [26,27].
Written informed consent was obtained from each patient. The ethics committee of the Charit? University Hospital approved the protocol.
Transthoracic echocardiography was performed according to the ASE recommendations  by Vivid 7 Dimension (M3S 1.5?4.0 MHz transducer; GE Vingmed, Horton, Norway). The images were stored digitally and analyzed off-line by EchoPac PC Dimension (GE Vingmed, Horton Norway). Echocardiographic examinations included the trans-mitral inflow profile (E/A), TDI measurement of the ratio of the early-to-late annular velocity (E'/A') in the basal septum and left lateral myocardium at the mitral annulus, the E/E' ratio using the average of the basal septal and basal lateral E', the systolic basal septal and lateral myocardial velocities (S') as well as basal septal and lateral Strain and longitudinal displacement. (For acquisition of the TDI images: see additional file 1 and additional file 2]. All measurements were performed in the apical four chamber view; three beats were stored and analyzed.
The LVEF was calculated according to Simpson's rule . A normal LVEF was defined as ? 55%, 30?55% is mild-moderately abnormal, a LVEF < 30% is severely abnormal according to . LV mass was computed according to the ASE cube method .
Diastolic heart failure was defined as previously described: normal LVEF (? 55%) , E/E' > 10 [13,14], E/A < 1 [32,33]. The transmital flow and TDI parameters were adjusted to age-related cut-points according to [33,34].
The patients were classified as normal controls (group 1), diastolic heart failure with preserved left ventricular function (LVEF ? 55%, group 2), systolic heart failure (LVEF < 55%, group 3).
Statistics were calculated by SPSS (version 12.0, Chicago, Ill, USA). Descriptive statistics of parametric variables are expressed as mean (? SD). Nonparametric variables are expressed as median (inter-quartile range, IQR, of 25 and 75 percentiles).
The comparison of echocardiographic parameters between groups was calculated by Wilcoxon test for non-parametric data. The Dunnett test was used for comparison to normal findings . Dichotomized data were analyzed by the Chi2-test. The level of significance was p = 0.05.
ROC (Receiver Operator Characteristics) analysis was performed to calculate sensitivity, specificity, negative and positive predictive values and an optimal cut-point of NT-proBNP to detect systolic or diastolic dysfunction. The optimal cut-off point was assessed according to Youden .
137 patients were included. 42 patients had normal systolic and diastolic function (group 1), 43 patients had diastolic dysfunction (group 2), 52 patients had systolic dysfunction with an EF < 55% (group 3).
The baseline characteristics of the patients are listed in table 1; the echocardiographic findings are listed in table 2. Patients with reduced LVEF (< 55%) had significantly increased NT-proBNP values compared to the healthy controls. Strain and longitudinal displacement parameters were significantly reduced in severely reduced LVEF compared to controls (table 3, figure 1).
The ROC analysis to discriminate between normal LVEF (n = 88) and reduced LVEF (n = 49) had an area under the curve of 0.844, which indicates a good diagnostic accuracy. The best cut-off for this discrimination was 489 pg/ml (sensitivity 81.6%, specificity 85.2%, PPV 75.5% and NPV 89.3%, OR 25.6, Youden Index 0.67). The ROC analysis to discriminate between normal echocardiography (n = 42) and impaired diastolic and/or systolic function (n = 95) had an area under the curve of 0.763, which indicates a fair diagnostic accuracy. The best cut-off for this discrimination was 97 pg/ml (sensitivity 80.4%, specificity 64.3%, PPV 83.5% and NPV 58.7%, OR 7.2, Youden Index 0.44) (figure 2)
Dividing the patients with preserved systolic LV function (groups 1 and 2) by E/E' (cut-point = 8) showed that there were significant differences in NT-proBNP levels (E/E' < 8: median NT-proBNP: 45.8, IQR: 172.6 pg/ml, E/E' > 8: 114.6 (261.7), p = 0.01). Classifying these patients by E/E' < 8, E/E' 8?15 and E/E' > 15 according to [14,33] revealed that those with increased filling pressures (E/E' > 15) had significantly elevated NT-proBNP and reduced longitudinal displacement values compared to patients with E/E' < 8. Strain, in contrast, was not significantly impaired. The patients with an E/E' 8?15 did not differ significantly in NT-proBNP levels compared to patients with E/E' < 8 or E/E' > 15 (figures 3 and 4).
A division by E/A (cut-point = 1, p = 0.34) or E'/A' (cut-point = 1, p = 0.54) was not associated with significantly different NT-proBNP levels. This indicates that increased E/E' is most closely linked to elevated NT-proBNP.
There was a correlation of peak systolic velocities (S') and longitudinal displacement with NT-proBNP throughout the spectrum of our patients (Spearman correlation coefficient was -0.578 (p < 0.0001) for longitudinal displacement and -0.605 (p < 0.001) for S').
The main finding of this study is that patients with diastolic and systolic myocardial dysfunction have significantly reduced basal left ventricular septal and lateral strain compared to healthy controls. Patients with normal LVEF and elevated left ventricular filling pressures (E/E' > 15) have significantly reduced longitudinal displacement and significantly elevated NT-proBNP. NT-proBNP can detect patients with a reduced left ventricular systolic function (LVEF < 55%) with a good diagnostic accuracy in accordance with previous studies [19-24].
In the patients with normal LV function and an elevated E/E' (8 ? 15), the measurement of NT-proBNP does not add a significant diagnostic information. Therefore, the diagnostic accuracy of NT-proBNP to detect diastolic dysfunction in these patients is low. Our findings do not fully support the algorithm recently published consensus statement for the diagnosis of diastolic heart failure that emphasized E/E' and NT-proBNP .
In the grey zone of mildly elevated NT-proBNP and/or an E/E' between 8 and 15, it remains difficult to diagnose diastolic heart failure. This could be due to the weak correlation of invasively measured LA filling pressures and E/E' in this grey zone. The majority of patients with normal LVEF and invasively measured elevated LA filling pressures had an E/E' between 8 and 15 .
This underlines the importance of integrating multiple echocardiographic parameters and an individual interpretation by experienced cardiologists. Especially in the case of elevated NT-proBNP of non-cardiac causes (e.g. renal failure), the diagnostic work-up has to rely on echocardiography alone. In these borderline cases, invasive measurements by a conductance catheter should be considered to exclude relevant diastolic dysfunction .
Why is NT-proBNP not significantly elevated in diastolic dysfunction compared to healthy controls, but correlates to filling pressures (E/E')? We speculate that diastolic dysfunction is a process that includes a variety of mechanisms (LV hypertrophy, abnormal active relaxation, increased stiffness, increased filling pressures). The trigger for NT-proBNP release from cardiomyocytes is primarily wall stress, which is functionally reflected by filling pressures (E/E').
Our findings support the "single syndrome" theory of heart failure. Subtle changes of longitudinal myocardial function (reflected by Strain and longitudinal displacement) begin in diastolic heart failure and are further increased in systolic heart failure. However, the study by Yip  has seen a progressive decline of left ventricular long axis function (systolic peak mitral annular velocity) in patients with diastolic heart failure compared to healthy controls. We found that peak systolic velocities are not significantly reduced in diastolic dysfunction. The cut-off of a normal ejection fraction in their study was 45%. According to , a normal LVEF is ? 55%. For this reason, the results of  are possibly explained by inclusion bias of patients with reduced LVEF. In their study neither E/E', Strain or Tracking were measured. In concordance with our results, Dong  did not note a reduction of TDI systolic velocity (S') in patients with diastolic dysfunction.
The cut-off values of LVEF, NT-proBNP and E/E' need to be discussed, because the different studies have used different cut-offs. The definition of a normal LVEF > 50% in the ESC Guidelines  is somewhat arbitrary. Lang  has suggested 55% as the cut-off for a normal LVEF (used in our study). The lower threshold of 50% will automatically include patients with impairment of longitudinal function and will therefore alter the sensitivity and specificity for the detection diastolic dysfunction.
The NT-proBNP values physiologically increase with age ; therefore the threshold of 220 pg/ml in the Guidelines by Paulus  will lead to impaired diagnostic accuracy and false-positives in the elderly patients.
In conclusion, we found that in patients with systolic and diastolic heart failure, E/E', NT-proBNP as well as Strain and longitudinal displacement add important incremental information for the severity estimation of heart failure. In patients with isolated diastolic dysfunction, Strain is significantly reduced and with increased fillings pressures longitudinal displacement is impaired, paralleled by an increase of NT-proBNP. But in a substantial subset of patients with borderline NT-proBNP and E/E', an individual analysis of all available data has to be performed.
We have excluded patients with atrial fibrillation because of the difficulty to assess certain diastolic function parameters (trans-mitral E/A and myocardial E'/A'). We have only measured NT-proBNP and not BNP, because recent head-to-head studies found that BNP and NT-proBNP can be used comparably . We have not classified diastolic dysfunction according to restrictive, pseudo-normal or impaired relaxation. But previous studies have shown that NT-proBNP is strongly elevated in patients with pseudo-normal and restrictive filling patterns . In the group of patients with normal LVEF, there were no patients with pseudo-normalization or restrictive diastolic dysfunction. No follow-up of the patients or invasive measurements were performed.
NT-proBNP: N-terminal-pro-Brain Natriuretic Peptide; PPV: Positive Predictive Value; NPV: Negative Predictive Value; ROC: Receiver Operator Characteristic; LVMI: Left Ventricular Mass Index; BMI: Body Mass Index.
The authors declare that they have no competing interests.
FK, SE, MB and ACB have designed the study and have acquired the data. SS, VR, SE, IS, MB participated in contributions to conception and, or analysis and interpretation of data. FK has written the manuscript. GB has supervised and commented the study. ACB was the supervisor of echo examinations, is head of the echo lab, contributed by revising the manuscript critically. All authors read and approved the final manuscript.
TDI image of the interventricular septum. Acquisition of a TDI image in the apical four chamber view.
Click here for additional data file (1476-7120-6-45-S1.wmv)
Additional file 2
How to perform the TDI analysis. Illustration of the correct acquisition a TDI region of interest (= ROI) in the basal left-ventricular septum. The size of the ROI is adjusted to the septal diameter and then, the ROI is traced manually in each frame to avoid artifacts. This acquisition applies to Velocity, Strain Rate and Displacement.
Click here for additional data file (1476-7120-6-45-S2.wmv)
The authors like to thank Christine Scholz and Sania Mikovic for excellent technical assistance.
|Owan TE,Hodge DO,Herges RM,Jacobsen SJ,Roger VL,Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fractionN Engl J Med 2006;355:251–259. [pmid: 16855265] [doi: 10.1056/NEJMoa052256]|
|Owan TE,Redfield MM. Epidemiology of diastolic heart failureProg Cardiovasc Dis 2005;47:320–332. [pmid: 16003647] [doi: 10.1016/j.pcad.2005.02.010]|
|Yancy CW,Lopatin M,Stevenson LW,De Marco T,Fonarow GC,ADHERE Scientific Advisory Committee and InvestigatorsClinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) DatabaseJ Am Coll Cardiol 2006;47:76–84. [pmid: 16386668] [doi: 10.1016/j.jacc.2005.09.022]|
|Abhayaratna WP,Marwick TH,Smith WT,Becker NG. Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic surveyHeart 2006;92:1259–1264. [pmid: 16488928] [doi: 10.1136/hrt.2005.080150]|
|Liao L,Jollis JG,Anstrom KJ,Whellan DJ,Kitzman DW,Aurigemma GP,Mark DB,Schulman KA,Gottdiener JS. Costs for heart failure with normal vs reduced ejection fractionArch Intern Med 2006;166:112–118. [pmid: 16401819] [doi: 10.1001/archinte.166.1.112]|
|Aurigemma GP,Gaasch WH. Clinical practice. Diastolic heart failureN Engl J Med 2004;351:1097–1105. [pmid: 15356307] [doi: 10.1056/NEJMcp022709]|
|Arias MA,Alonso A,Garcia-Rio F. Diastolic heart failureN Engl J Med 2005;352:307–308. [pmid: 15659738] [doi: 10.1056/NEJM200501203520321]|
|Zile MR,Baicu CF,Gaasch WH. Diastolic heart failure?abnormalities in active relaxation and passive stiffness of the left ventricleN Engl J Med 2004;350:1953–1959. [pmid: 15128895] [doi: 10.1056/NEJMoa032566]|
|Yip G,Wang M,Zhang Y,Fung JW,Ho PY,Sanderson JE. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition?Heart 2002;87:121–125. [pmid: 11796546] [doi: 10.1136/heart.87.2.121]|
|Sanderson JE. Diastolic heart failure: fact or fiction?Heart 2003;89:1281–1282. [pmid: 14594874] [doi: 10.1136/heart.89.11.1281]|
|Sanderson JE. Heart failure with a normal ejection fractionHeart 2007;93:155–158. [pmid: 16387829] [doi: 10.1136/hrt.2005.074187]|
|Paulus WJ,Tschope C,Sanderson JE,Rusconi C,Flachskampf FA,Rademakers FE,Marino P,Smiseth OA,De Keulenaer G,Leite-Moreira AF,Borbely A,Edes I,Handoko ML,Heymans S,Pezzali N,Pieske B,Dickstein K,Fraser AG,Brutsaert DL. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of CardiologyEur Heart J 2007;28:2539–2550. [pmid: 17428822] [doi: 10.1093/eurheartj/ehm037]|
|Khouri SJ,Maly GT,Suh DD,Walsh TE. A practical approach to the echocardiographic evaluation of diastolic functionJ Am Soc Echocardiogr 2004;17:290–297. [pmid: 14981433] [doi: 10.1016/j.echo.2003.08.012]|
|Nagueh SF,Middleton KJ,Kopelen HA,Zoghbi WA,Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressuresJ Am Coll Cardiol 1997;30:1527–1533. [pmid: 9362412] [doi: 10.1016/S0735-1097(97)00344-6]|
|Sutherland GR,Di Salvo G,Claus P,D'hooge J,Bijnens B. Strain and strain rate imaging: a new clinical approach to quantifying regional myocardial functionJ Am Soc Echocardiogr 2004;17:788–802. [pmid: 15220909] [doi: 10.1016/j.echo.2004.03.027]|
|Heimdal A,Stoylen A,Torp H,Skjaerpe T. Real-time strain rate imaging of the left ventricle by ultrasoundJ Am Soc Echocardiogr 1998;11:1013–1019. [pmid: 9812093] [doi: 10.1016/S0894-7317(98)70151-8]|
|Yu CM,Sanderson JE,Marwick TH,Oh JK. Tissue Doppler imaging a new prognosticator for cardiovascular diseasesJ Am Coll Cardiol 2007;49:1903–1914. [pmid: 17498573] [doi: 10.1016/j.jacc.2007.01.078]|
|Borges AC,Kivelitz D,Walde T,Reibis RK,Grohmann A,Panda A,Wernecke KD,Rutsch W,Hamm B,Baumann G. Apical tissue tracking echocardiography for characterization of regional left ventricular function: comparison with magnetic resonance imaging in patients after myocardial infarctionJ Am Soc Echocardiogr 2003;16:254–262. [pmid: 12618734] [doi: 10.1067/mje.2003.15]|
|Lubien E,DeMaria A,Krishnaswamy P,Clopton P,Koon J,Kazanegra R,Gardetto N,Wanner E,Maisel AS. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordingsCirculation 2002;105:595–601. [pmid: 11827925] [doi: 10.1161/hc0502.103010]|
|de Lemos JA,McGuire DK,Drazner MH. B-type natriuretic peptide in cardiovascular diseaseLancet 2003;362:316–322. [pmid: 12892964] [doi: 10.1016/S0140-6736(03)13976-1]|
|Tsch?pe C,Kasner M,Westermann D,Gaub R,Poller WC,Schultheiss HP. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurementsEur Heart J 2005;26:2277–2284. [pmid: 16014646] [doi: 10.1093/eurheartj/ehi406]|
|Goetze JP,Mogelvang R,Maage L,Scharling H,Schnohr P,Sogaard P,Rehfeld JF,Jensen JS. Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunctionEur Heart J 2006;27:3004–3010. [pmid: 17118955] [doi: 10.1093/eurheartj/ehl406]|
|Januzzi JL,van Kimmenade R,Lainchbury J,Bayes-Genis A,Ordonez-Llanos J,Santalo-Bel M,Pinto YM,Richards M. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP StudyEur Heart J 2006;27:330–337. [pmid: 16293638] [doi: 10.1093/eurheartj/ehi631]|
|Wu AH,Harrison A,Maisel AS. Reduced readmission rate for alternating diagnoses of heart failure and pulmonary disease after implementation of B-type natriuretic peptide testingEur J Heart Fail 2004;6:309–312. [pmid: 14987581] [doi: 10.1016/j.ejheart.2003.12.014]|
|Sokoll LJ,Baum H,Collinson PO,Gurr E,Haass M,Luthe H,Morton JJ,Nowatzke W,Zingler C. Multicenter analytical performance evaluation of the Elecsys proBNP assayClin Chem Lab Med 2004;42:965–972. [pmid: 15387451] [doi: 10.1515/CCLM.2004.157]|
|National Kidney FoundationK/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationAm J Kidney Dis 2002;39:S1–266. [pmid: 11904577]|
|Cockcroft DW,Gault MH. Prediction of creatinine clearance from serum creatinineNephron 1976;16:31–41. [pmid: 1244564] [doi: 10.1159/000130554]|
|Sahn DJ,DeMaria A,Kisslo J,Weyman A. The Committee on M-mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in Mmode echocardiography: results of a survey of echocardiographic measurementsCirculation 1978;58:1072–1083. [pmid: 709763]|
|Schiller NB,Shah PM,Crawford M,DeMaria A,Devereux R,Feigenbaum H,Gutgesell H,Reichek N,Sahn D,Schnittger I. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional EchocardiogramsJ Am Soc Echocardiogr 1989;2:358–367. [pmid: 2698218]|
|Lang RM,Bierig M,Devereux RB,Flachskampf FA,Foster E,Pellikka PA,Picard MH,Roman MJ,Seward J,Shanewise JS,Solomon SD,Spencer KT,Sutton MS,Stewart WJ,Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of EchocardiographyRecommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of CardiologyJ Am Soc Echocardiogr 2005;18:1440–1363. [pmid: 16376782] [doi: 10.1016/j.echo.2005.10.005]|
|Devereux R,Alonso D,Lutas E,Gottlieb G,Campo E,Sachs I,Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findingsAm J Cardiol 1986;57:450–458. [pmid: 2936235] [doi: 10.1016/0002-9149(86)90771-X]|
|Sohn DW,Chai IH,Lee DJ,Kim HC,Kim HS,Oh BH,Lee MM,Park YB,Choi YS,Seo JD,Lee YW. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic functionJ Am Coll Cardiol 1997;30:474–480. [pmid: 9247521] [doi: 10.1016/S0735-1097(97)88335-0]|
|Perez-David E,Garcia-Fernandez MA,Ledesma MJ,Malpica N,Lopez Fernandez T,Santos A,Moreno M,Antoranz JC,Bermejo J,Desco M. Age-related intramyocardial patterns in healthy subjects evaluated with Doppler tissue imagingEur J Echocardiogr 2005;6:175–185. [pmid: 15894236] [doi: 10.1016/j.euje.2004.08.007]|
|Bess RL,Khan S,Rosman HS,Cohen GI,Allebban Z,Gardin JM. Technical aspects of diastology: why mitral inflow and tissue Doppler imaging are the preferred parameters?Echocardiography 2006;23:332–339. [pmid: 16640715] [doi: 10.1111/j.1540-8175.2006.00215.x]|
|Dunnett CW. Multiple Comparisons Procedure for Comparing Several Treatments with a ControlJournal of the American Statistical Association 1957;50:1096–1121. [doi: 10.2307/2281208]|
|Youden WJ. An index for rating diagnostic testsCancer 1950;3:32–35. [pmid: 15405679] [doi: 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3]|
|Ommen SR,Nishimura RA,Appleton CP,Miller FA,Oh JK,Redfield MM,Tajik AJ. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization studyCirculation 2000;102:1788–1794. [pmid: 11023933]|
|Kasner M,Westermann D,Steendijk P,Gaub R,Wilkenshoff U,Weitmann K,Hoffmann W,Poller W,Schultheiss HP,Pauschinger M,Tsch?pe C. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization studyCirculation 2007;116:637–647. [pmid: 17646587] [doi: 10.1161/CIRCULATIONAHA.106.661983]|
|Dong SJ,de las Fuentes L,Brown AL,Waggoner AD,Ewald GA,Davila-Roman VG. N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohortJ Am Soc Echocardiogr 2006;19:1017–1025. [pmid: 16880097] [doi: 10.1016/j.echo.2006.03.012]|
|Hess G,Runkel S,Zdunek D,Hitzler WE. Reference interval determination for N-terminal-B-type natriuretic peptide (NT-proBNP): a study in blood donorsClin Chim Acta 2005;360:1–2. [pmid: 15979602] [doi: 10.1016/j.cccn.2005.04.031]|
Baseline characteristics of the patients (mean ? SD, for non-parametric values: median, inter-quartile range) p compared to normal.
|All patients (n= 137)||Normal (n= 42)||Diastolic dysfunction (n = 43)||Systolic dysfunction (n = 52)||p (compared to normal)|
|Male sex (%)||88 (65)||23 (55)||23 (54)||43 (83)||1.00/0.0059|
|Age [y]||53.8 (? 18.1)||37.8 (? 15.9)||62.7 (? 12.5)||59.5 (? 15.2)||< 0.0001/< 0.0001|
|BMI [kg/m2]||25.54 (? 4.36)||23.8 (? 3.4)||26.5 (? 3.8)||26.2 (? 5.1)||0.011/0.018|
|NT-proBNP [pg/ml]||2378 ? 6253, (median 222 (? 1220)||275.9 ? 519.9 (median 66.8, ? 185.3)||255.9 ? 137.4(median 137, ? 256.7)||5832 ? 9185(median 1583, ? 5109)||0.36/<0.0001|
|Creatinine clearance [ml/min]||87.48 (? 37.89)||107.9 (? 28.6)||82.1 (? 35.0)||78.5 (? 41.3)||0.003/0.0002|
|Heart rate [/s]||71.6 (? 13.6)||68.3 (? 13.9)||73.1 (? 13.1)||73.5 (? 13.5)||0.68/0.17|
|Systolic RR [mmHg]||123.0||123.0||136.8||115.4||0.01/0.19|
|Diastolic RR [mmHg]||74.0||75.4||80.0||71.2||0.21/0.23|
|coronary artery disease (%)||41 (30)||1 (2)||10 (23)||28 (54)||0.0077/0.001|
|previous myocardial infarction (%)||28 (20)||0||5 (12)||21 (40)||0.06/0.0001|
|arterial hypertension (%)||63 (46)||11 (26)||27 (63)||25 (48)||0.0008/0.049|
|diabetes mellitus (%)||25 (18)||3 (7)||3 (7)||18 (35)||1.00/0.0046|
|Hyperlipidemia (%)||40 (29)||2 (5)||15 (35)||22 (42)||0.0018/< 0.0001|
|Smoker (%)||27 (20)||10 (24)||9 (21)||9 (17)||0.8035|
|ischemic cardiomyopathy (%)||30 (22)||0||0||29 (56)||< 0.0001|
Echocardiographic findings. Mean ? SD
|Normal||Diastolic dysfunction||Systolic dysfunction||P (compared to normal)|
|LVEF (%)||59.5 (? 2.2)||59.1 (? 1.9)||31.5 (? 9.9)||0.99/< 0.0001|
|Fractional shortening (%)||0.38 (? 0.1)||0.39 (? 0.1)||0.16 (? 0.1)||0.58/< 0.0001|
|LVEDD (mm)||46.1 (? 4.2)||46.8 (? 5.5)||64.5 (? 12.2)||0.91/< 0.0001|
|LVESD (mm)||28.6 (? 5.9)||46.4 (? 5.7)||52.1 (? 15.0)||0.99/< 0.0001|
|PAP (mmHg)||26.1 (? 11.4)||27.0 (? 5.8)||38.4 (? 13.2)||0.94/0.0015|
|Septum (mm)||10.3 (? 1.9)||12.0 (? 2.8)||11.5 (? 2.0)||0.02/0.0007|
|Posterior wall (mm)||10.2 (? 1.7)||11.7 (? 1.8)||11.7 (? 1.5)||0.001/< 0.0001|
|E/A transmitral||1.5 (? 0.5)||0.9 (? 0.2)||1.3 (? 0.8)||< 0.0001/0.36|
|Left ventricular mass [mg]||195.4 (? 59.5)||236.1 (? 58.3)||436.7 (175.9)||0.19/< 0.0001|
|LVMI||104.1 (? 26.6)||126.0 (? 28.7)||222.6 (? 84.8)||0.14/< 0.0001|
|Strain septal (%)||-24.8 (? 8.1)||-18.5 (? 5.3)||-16.1 (? 7.0)||< 0.0001/< 0.0001|
|Strain left lateral (%)||-21.9 (? 11.4)||-17.6 (? 6.0)||-14.1 (? 8.3)||0.04/< 0.0001|
|septal longitudinal displacement (mm)||12.9 (? 3.0)||11.8 (? 2.1)||6.7 (? 3.9)||0.19/< 0.0001|
|lateral longitudinal displacement (mm)||12.1 (? 3.4)||10.9 (? 2.9)||7.4 (? 4.0)||0.20/<0.0001|
|TVI velocity E septal (m/s)||0.09 (? 0.02)||0.05 (? 0.01)||0.04 (? 0.02)||< 0.0001/< 0.0001|
|TVI velocity A septal (m/s)||0.06 (? 0.02)||0.08 (? 0.02)||0.06 (? 0.08)||0.26/0.98|
|TVI velocity S septal (m/s)||0.06 (? 0.01)||0.06 (? 0.01)||0.04 (? 0.01)||0.14/< 0.0001|
|E/E'||9.14 (? 4.62)||11.44 (? 3.14)||20.56 (? 15.08)||0.44/<0.0001|
|E'/A'||1.94 (? 1.17)||0.88 (? 0.60)||1.35 (? 0.92)||< 0.0001/0.01|
NT-proBNP and Tissue Doppler echocardiography variables according to reduction in systolic function, n = 137. (median ? SD, IQR: inter quartile range for NT-proBNP)
|LVEF > 55%||LVEF 30?54%||LVEF < 30%||p vs normal|
|NT-proBNP||97.0 (180.5)||587.6 (2914.9)||3373.0 (6057)||< 0.001/< 0.001|
|septal longitudinal displacement [mm]||11.5 (? 3.2)||9.3 (? 4.3)||4.9 (? 2.0)||0.015/< 0.001|
|lateral longitudinal displacement [mm]||12.6 (? 2.6)||8.7 (? 3.6)||4.1 (? 3.3)||< 0.001/< 0.001|
|Strain septal [%]||-21.1 (? 7.5)||-14.8 (? 6.9)||-15.4 (? 7.4)||0.001/0.002|
|Strain lateral [%]||-19.1 (? 9.3)||-16.1 (? 9.0)||-10.0 (? 5.2)||0.130/< 0.001|
|TVI S' [m/s] septal||0.09 (? 0.07)||0.06 (? 0.03)||0.04 (? 0.02)||0.002/< 0.001|
|TVI S' [m/s] lateral||0.06 (? 0.03)||0.05 (? 0.02)||0.03 (? 0.02)||< 0.001/< 0.001|
|E/E'||9.5 (? 4.1)||12.3 (? 12.0)||19.3 (? 16.6)||0.063/< 0.001|
Previous Document: Pulmonary inflammation and tumor induction in lung tumor susceptible A/J and resistant C57BL/6J mice...
Next Document: Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Pan...